Fig. 1 · Structure
Documents & Downloads
Insulin glulisine
Insulin Analog
Insulin glulisine is a rapid-acting insulin analog that mimics physiological insulin secretion, characterized by a swift onset of action. It effectively regulates hyperglycemia, making it a valuable tool for research in type 1 and type 2 diabetes. This compound plays a critical role in the study of insulin dynamics and glucose metabolism, facilitating investigations into diabetes management and treatment strategies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 207748-29-6 |
| Applications | Insulin Analog |
| Formula | C258H384N64O78S6 |
| Molecular Weight | 5822.57 |
| Synonyms | HMR 1964 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.